title: JAK2V617F and CALR double mutations are more frequently encountered in patients with low JAK2V617F allelic burdens.
authors.affiliation: a Laboratoire d'Hématologie , CHU de Bordeaux ;|b Hématopoïèse leucémique et cibles thérapeutiques, INSERM U1035, Université de Bordeaux ;
authors.forename: Olivier
authors.initials: O
authors.lastname: Mansier
authors.affiliation: a Laboratoire d'Hématologie , CHU de Bordeaux ;
authors.forename: Marina
authors.initials: M
authors.lastname: Migeon
authors.affiliation: c Département d'Hématologie , Institut Bergonié , Bordeaux, France.
authors.forename: Gabriel
authors.initials: G
authors.lastname: Etienne
authors.affiliation: a Laboratoire d'Hématologie , CHU de Bordeaux ;
authors.forename: Audrey
authors.initials: A
authors.lastname: Bidet
authors.affiliation: a Laboratoire d'Hématologie , CHU de Bordeaux ;|b Hématopoïèse leucémique et cibles thérapeutiques, INSERM U1035, Université de Bordeaux ;
authors.forename: Eric
authors.initials: E
authors.lastname: Lippert
mesh_terms: D000483:Alleles; D006801:Humans; D053614:Janus Kinase 2 / Q000235:genetics*; D009154:Mutation; D013920:Thrombocythemia, Essential / Q000235:genetics*
chemical_list: D053614:Janus Kinase 2